Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression

• Published in: Acta neuropathologica communications 2019-07, Vol.7 (1), p.120-13, Article 120
• Main Authors: De, Suman, Whiten, Daniel R, Ruggeri, Francesco S, Hughes, Craig, Rodrigues, Margarida, Sideris, Dimitrios I, Taylor, Christopher G, Aprile, Francesco A, Muyldermans, Serge, Knowles, Tuomas P J, Vendruscolo, Michele, Bryant, Clare, Blennow, Kaj, Skoog, Ingmar, Kern, Silke, Zetterberg, Henrik, Klenerman, David
• Format: Article
• Language: English
• Subjects: a-beta oligomer; Advertising executives; Alzheimer's disease; amyloid-beta; amyloid-beta(1-42); Atomic force microscopy; ca2+ influx; cellular toxicity; Cerebrospinal fluid; dimers; Disease mechanism; epitope; Microscopy; Mild cognitive impairment; Neurons; Neurosciences; Neurosciences & Neurology; Neurovetenskaper; Protein aggregation; Structure-function relation; Super-resolution imaging; Toxicity
• ISSN: 2051-5960; 2051-5960
• DOI: 10.1186/s40478-019-0777-4

Soluble aggregates of amyloid-β (Aβ) have been associated with neuronal and synaptic loss in Alzheimer's disease (AD). However, despite significant recent progress, the mechanisms by which these aggregated species contribute to disease progression are not fully determined. As the analysis of human cerebrospinal fluid (CSF) provides an accessible window into the molecular changes associated with the disease progression, we characterised soluble aggregates present in CSF samples from individuals with AD, mild cognitive impairment (MCI) and healthy controls using a range of sensitive biophysical methods. We used super-resolution imaging and atomic force microscopy to characterise the size and structure of the aggregates present in CSF and correlate this with their ability to permeabilise lipid membranes and induce an inflammatory response. We found that these aggregates are extremely heterogeneous and exist in a range of sizes, varying both structurally and in their mechanisms of toxicity during the disease progression. A higher proportion of small aggregates of Aβ that can cause membrane permeabilization are found in MCI CSF; in established AD, a higher proportion of the aggregates were larger and more prone to elicit a pro-inflammatory response in glial cells, while there was no detectable change in aggregate concentration. These results show that large aggregates, some longer than 100 nm, are present in the CSF of AD patients and suggest that different neurotoxic mechanisms are prevalent at different stages of AD.